Management of IgA nephropathy: Evidence-based recommendations

Slides:



Advertisements
Similar presentations
Plasma sodium and hypertension
Advertisements

Viper venom for diabetic nephropathy
Anemia management in chronic kidney disease
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
Sustainable and tenable renal health model: A Latin American proposal of classification, programming, and evaluation  Rafael Burgos Calderón, Santos Depine 
Progression of renal failure and hypertensive nephrosclerosis
Volume 53, Issue 4, Pages (April 1998)
Volume 73, Pages S53-S68 (April 2008)
Volume 65, Issue 6, Pages (June 2004)
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Volume 80, Issue 9, Pages (November 2011)
Volume 74, Issue 3, Pages (August 2008)
Gary C.W. Chan, Sydney C.W. Tang  Kidney International 
The epidemiology of chronic kidney disease
Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension  A. Davenport, C. Cox, R. Thuraisingham  Kidney.
Volume 73, Pages S5-S17 (April 2008)
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Blood pressure targets in hemodialysis patients
Frank Eitner, Jürgen Floege  Kidney International 
Volume 76, Issue 5, Pages (September 2009)
Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect?  Areef Ishani, Charles A. Herzog,
David M. Charytan, John P. Forman  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Volume 85, Issue 3, Pages (March 2014)
Capturing the in vivo molecular signature of the podocyte
A physician's perseverance uncovers problems in a key nephrology study
The third World Kidney Day: Looking back and thinking forward
Volume 53, Issue 4, Pages (April 1998)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 63, Pages S38-S42 (February 2003)
Volume 65, Issue 4, Pages (April 2004)
Proteinuria and hypertensive nephrosclerosis in African Americans
The future of renoprotection: Frustration and promises
Microbiology and outcomes of peritonitis in North America
Nephrology Crossword: Peritoneal Dialysis
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes  J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.
IgA nephropathy at two score and one
Volume 85, Issue 1, Pages (January 2014)
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
Volume 69, Issue 8, Pages (April 2006)
Mechanisms of tubulointerstitial injury in IgA nephropathy
Volume 54, Pages S192-S194 (September 1998)
Volume 82, Issue 7, Pages (October 2012)
The course of the remnant kidney model in mice
Volume 73, Issue 5, Pages (March 2008)
Clinical benefits of slowing the progression of renal failure
Organ transplantation goes to the movies
Atherosclerotic nephropathy
Volume 55, Pages S3-S16 (June 1999)
Volume 77, Issue 1, Pages (January 2010)
Volume 68, Pages S98-S102 (December 2005)
Is it the low-protein diet or simply the salt restriction?
Volume 64, Issue 4, Pages (October 2003)
Charles A. Herzog  Kidney International 
The future of renoprotection
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Volume 80, Issue 9, Pages (November 2011)
Volume 57, Issue 2, Pages (October 2000)
Volume 55, Pages S41-S46 (June 1999)
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Volume 54, Pages S112-S119 (December 1998)
Volume 60, Issue 2, Pages (August 2001)
Antonio Piccoli, Luana Pillon  Kidney International 
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Management of IgA nephropathy: Evidence-based recommendations Linda Nolin, Maryse Courteau  Kidney International  Volume 55, Pages S56-S62 (June 1999) DOI: 10.1046/j.1523-1755.1999.07008.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Fig. 1 Decision tree for biopsy-proven IgA nephropathy (IgAN). Blood pressure in all cases should be controlled with angiotensin converting enzyme inhibitors (ACEI). Kidney International 1999 55, S56-S62DOI: (10.1046/j.1523-1755.1999.07008.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Fig. 2 Decision tree for biopsy-proven IgA nephropathy (IgAN) with a rapidly progressive course. Kidney International 1999 55, S56-S62DOI: (10.1046/j.1523-1755.1999.07008.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Fig. 3 Decision tree for IgA proven nephropathy with macroscopic hematuria. Kidney International 1999 55, S56-S62DOI: (10.1046/j.1523-1755.1999.07008.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.